[Methylprednisolone sodium succinate in the profile of respiratory complications after thoracic surgical intervention].
Methylprednisolone sodium succinate (MPSS) was compared in a randomized double blind study to placebo in the prevention of respiratory complications in 40 patients submitted to thoracic surgery. The results indicate that the patients who received MPSS showed a lower incidence of respiratory complications, adverse reactions, chest pain and metabolic acidosis.
Launo
C
C
Instituto di Anestesiologia e Rianimazione, Università degli Studi di Genova.
Palermo
S
S
Gobbi
G C
GC
Fumagalli
C
C
Federici
E
E
Moroni
G
G
D000328:Adult; D000368:Aged; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007431:Intraoperative Complications / Q000517:prevention & control*; D008297:Male; D008776:Methylprednisolone Hemisuccinate / Q000627:therapeutic use*; D008875:Middle Aged; D010919:Placebos; D013903:Thoracic Surgery
D010919:Placebos; D008776:Methylprednisolone Hemisuccinate
Il metilprednisolone sodio succinato nella profilassi delle complicanze respiratorie dopo interventi di chirurgia toracica.